NASDAQ:GBT
Delisted

Global Blood Therapeutics Stock Signals

etoro logo Buy GBT
*Your capital is at risk
$68.49
+0 (+0%)
At Close: Jan 27, 2023

Latest Data & Signals Issued

Below are some of the latest signals issued for GLOBAL BLOOD THERAPEUTICS

General

Signal Type Signal Value Data
Score 0.000 154 days ( -157.09 %
Last Price $68.49 0 %
Performance History
7 Days
$68.49 $68.49
0%
30 Days
$68.49 $68.49
0%
12 Mos
$25.68 $68.49
166.71%

6/18

Active Buy Signals

Specific Signals

Short Term
Net score: 25
Signal Type Signal Value Importance Data
High / Low N/A Very Low $68.49 - $68.49
Trend - 3 mos 0 % High Width: 0.0000000000003 %
Pred. range - 3 mos $68.49 - $68.49 Low 0 % - 0 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Jan 26, 2023 - 2 days
RSI Short Pivot Signal Sell Very Low Nov 30, -0001 - N/A days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 60.24
Signal Type Signal Value Importance Data
Trend - 12 mos 163.53 % Very High Width: 58.22 %
Pred. range - 12 mos $151.72 - $240.06 High 121.52 % - 250.50 %
Short MA 12 mos Sell Very High Sep 23, 2022 - 87 days
Long MA 12 mos Buy Very High Jun 28, 2022 - 148 days
Short/Long MA 12 mos Buy Very High Jul 01, 2022 - 145 days
Pivot Long Sell Low Jan 26, 2023 - 2 days
RSI Long Pivot Signal Sell Low Oct 27, 2022 - 63 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT GLOBAL BLOOD THERAPEUTICS
GLOBAL BLOOD THERAPEUTICS
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE